The molecular mechanisms by which low concentrations of MASL selectively damaged tumor cells remain to be clarified, but modifications of intrinsic and extrinsic anti-apoptosis pathways may be involved (Figure 3, Figure 4 and Figure 5E,F). The gene discussed is MAS1L; the disease is neoplasm.